Feider Stephen 4

What Happened

• Stephen Feider, Chief Financial Officer of Beta Bionics (BBNX), sold 6,676 shares on 2026-06-02 in an open-market or private sale. The reported proceeds were approximately $84,165. The sale was disclosed on a Form 4 filed 2026-06-03.
• This was a sale to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs), per the filing footnote — a routine, non-investment-motivated transaction.

Key Details

• Transaction date: 2026-06-02; Form 4 filed: 2026-06-03 (appears timely).
• Shares sold: 6,676; Reported total proceeds: $84,165.
• Prices: weighted average sale price $12.6071; reported range $12.30–$12.93. The filing notes full per-price detail is available upon request.
• Footnotes: F1 — sale made to cover tax withholding on RSU vesting; F2 — weighted average and price range disclosed, full breakdown available on request.
• Shares owned after transaction: not disclosed in the provided filing.

Context

• Sales to cover tax withholding for vested RSUs are common and generally considered routine cash-management transactions rather than a signal of insider sentiment. No options were exercised and no 10% owner or gift activity is involved in this filing.